ALLISON HUGHES: Open Payments
NPI 1902449499 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,354 in 85 payments from 19 companies in 2025. Trend: 2023 $1,316 · 2024 $1,329 · 2025 $1,354
Food & beverage: $1,354
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $253 |
| Merck Sharp & Dohme LLC | 9 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $138 |
| E.R. Squibb & Sons, L.L.C. | 17 | $138 |
| SCPHARMACEUTICALS INC. | 4 | $101 |
| Philips North America LLC | 4 | $92 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $73 |
| PFIZER INC. | 4 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| Abbott Laboratories | 2 | $51 |
Products named: LEQVIO, Kerendia, VERQUVO, FUROSCIX, CAMZYOS, Ambulatory Monitoring & Diagnostics Undivided, ELIQUIS, LifeVest.
Industry payments across FL — which companies pay providers there.
